Cargando…
Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism
Picropodophyllin (PPP) is an anticancer drug undergoing clinical development in NSCLC. PPP has been shown to suppress IGF-1R signaling and to induce a G2/M cell cycle phase arrest but the exact mechanisms remain to be elucidated. The present study identified an IGF-1-independent mechanism of PPP lea...
Autores principales: | Waraky, Ahmed, Akopyan, Karen, Parrow, Vendela, Strömberg, Thomas, Axelson, Magnus, Abrahmsén, Lars, Lindqvist, Arne, Larsson, Olle, Aleem, Eiman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226690/ https://www.ncbi.nlm.nih.gov/pubmed/25268741 |
Ejemplares similares
-
Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: Clinical implications
por: FENG, XIAOYING, et al.
Publicado: (2011) -
Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)
por: Hashemi, Jamileh, et al.
Publicado: (2011) -
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
por: Bieghs, Liesbeth, et al.
Publicado: (2014) -
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2011) -
Reorganization of paclitaxel-stabilized microtubule arrays at mitotic entry: roles of depolymerizing kinesins and severing proteins
por: Leung, Jessica C., et al.
Publicado: (2019)